Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 1, 2007, Pages 108-112

  Brueck, Martin ^a   Kramer, Wilfried ^a   Vogt, Paul ^b   Steinert, Nicole ^b   Roth, Peter ^b   Görlach, Gerold ^b   Schönburg, Markus ^c   Heidt, Martin C ^b  

^a Clinic of Wetzlar   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Anticoagulation; Antiplatelets; Prosthesis; Thromboembolism; Valves

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; BLEEDING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINUS RHYTHM; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; AORTIC VALVE; ASPIRIN; BIOPROSTHESIS; DRUG EVALUATION; EPIDEMIOLOGIC METHODS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; THROMBOEMBOLISM; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 34249939198     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.03.031     Document Type: Article

References (20)

1. Butchart E.G., Gohlke-Bärwolf C., Antunes M.J., Tornos P., de Caterina R., Cormier B., Prendergast B., Iung B., Bjornstad H., Leport C., Hall R.J., Vahanian A., and on behalf of the Working Groups on Valvular Heart Disease. Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 26 (2005) 2463-2471
2. Heras M., Chesebro J.H., Fuster V., Penny W.J., Grill D.E., Bailey K.R., Danielson G.K., Orszulak T.A., Pluth J.R., Puga F.J., Schaff H.V., and Larsonkeller J.J. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 25 (1995) 1111-1119
3. Vaughan P., and Waterworth P.D. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair. J Heart Valve Dis 14 (2005) 576-580
4. Bonow R.O., Carabello B., Chatterjee K., de Leon Jr. A.C., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Page R.L., and Riegel B. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 48 (2006) 598-675
5. Edmunds L.M., Clark R.E., Cohn L.M., Miller D.C., and Weiser R. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 46 (1988) 257-259
6. Ruel M., Masters R.G., Rubens F.D., Bedard P.J., Pipe A.L., Goldstein W.G., Hendry P.J., and Mesana T.G. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg 78 (2004) 77-83
7. Chesebro J.H., and Fuster V. Valvular heart disease and prosthetic heart valves. In: Fuster V., and Verstraete M. (Eds). Thrombosis in cardiovascular disorders (1992), Saunders, Philadelphia 192-214
8. Edmunds Jr. L.H. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 44 (1987) 430-445
9. Soots G., Pieronne A., Roux J.P., Stankowiak C., Warembourg Jr. H., Watel A., Prat A., Segbeya A., Maatouk M., and Crepin F. Experience with 813 aortic and mitral valve replacements with the Carpentier-Edwards bioprosthesis: five year results. Eur Heart J 5 Suppl. D (1984) 87-94
10. Seguin J.R., Grandmougin D., Folliquet T., Warembourg H., Laborde F., and Chaptal P.A. Long term results with the Sorin Pericarbon valve in the aortic position: a multicenter study. J Heart Valve Dis 7 (1998) 278-282
11. Jamieson W.R., Lemieux M.D., Sullivan J.A., Munro I.A., Metras J., and Cartier P.C. Medtronic intact porcine bioprosthesis: 10 years' experience. Ann Thorac Surg 66 Suppl 6 (1998) 118-121
12. Hartz R.S., Fisher E.B., Finkelmeier B., BeBoer A., Sanders Jr. J.H., Moran J.M., and Michaelis L.L. An eight-year experience with orcine bioprosthetic cardiac valves. J Thorac Cardiovasc Surg 91 (1986) 910-917
13. Moinuddeen K., Quin J., Shaw R., Dewar M., Tellides G., Kopf G., and Elefteriades J. Anticoagulation is unnecessary after biological aortic valve replacement. Circulation 98 Suppl. 19 (1998) II95-II98
14. Babin-Ebell J., Schmidt W., Eigel P., and Elert O. Aortic bioprosthesis without early anticoagulation-risk of thromboembolism. Thorac Cardiovasc Surg 43 (1995) 212-214
15. Bortolotti U., Milano A., Mazzucco A., Guerra F., Estolin L., Thiene G., and Gallucci V. Extended follow-up of the standard Hancock porcine bioprosthesis. J Card Surg 6 Suppl. (1991) 544-549
16. Atkins C.W., Carroll D.L., Buckley M.J., Daggett W.M., Hilgenberg A.D., and Austen W.G. Late results with Carpentier-Edwards porcine bioprosthesis. Circulation 82 Suppl. IV (1990) IV-65-IV-74
17. Sundt T.M., Zehr K.J., Dearani J.A., Daly R.C., Mullany C.J., McGregor C.G., Puga F.J., Orszulak T.A., and Schaff H.V. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg 129 (2005) 1024-1031
18. Oyer P.E., Stinson E.B., Reitz B.A., Miller D.C., Rossiter S.J., and Shummay N.E. Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg 78 (1979) 343-350
19. Gherli T., Colli A., Fragnito C., Nicolini F., Borrello B., Saccani S., D'Amico R., and Beghi C. Comparing warfarin with aspirin after biological aortic valve replacement. Circulation 110 (2004) 496-500
20. Blair K.L., Hatton A.C., White W.D., Smith L.R., Lowe J.E., Wolfe W.G., Young W.G., Oldham H.N., Douglas J.M., and Glower D. Comparison of anticoagulation regimes after Carpentier-Edwards aortic or mitral valve replacement. Circulation 90 Pt. 2 (1994) II-214-II-219